Parameter | Score |
---|---|
1. Scale | A |
2. Study Population | A |
3. Samples | A |
4. Measurand | A |
5. Pre-Analytical | A |
6. Replicate Analysis | A |
7. Steady State | C |
8. Outlier Analysis | C |
9. Normality | A |
10. Variance Homogeneity | A |
11. ANOVA | A |
12. CI | A |
13. No of Results | A |
14. Concentrations | A |
15. Total Score | C7,8 |
Comment |
Parameter | Score |
---|---|
Matrix | Serum |
Measurand | Copper |
Unit | ug / dL |
Overall Analytical Principle Method | MS; ICP-MS |
Number of Subjects | 15 |
Number of Subjects included in BV estimation | 13 |
Ethinicity | Caucasian |
Age Mean / Median | |
Age Min | 20.0 |
Age Max | 45.0 |
Age SD | |
Number of Males | |
Number of Females | |
State of Well Being |
Healthy (excl pregnant)
|
Diseases | |
Study Duration Length | 10 |
Study Duration Units | Week |
Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
Interval Units | Week |
Sampling Times | Start Time:
09.00
End Time: 10.00 |
Number of Samples | 10 |
Average Number of Samples Used for BV Estimation | 10.0 |
Average Number of Replicates | 2.0 |
Estimates of CVi | 7.1 |
Calculated Confidence Intervals of CVi | Lower: 5.42, Upper: 8.85 |
Estimates of CVg | 4.3 |
Calculated Confidence Intervals of CVg | Lower: 2.30, Upper: 7.85 |
Analytical CV | 8.4 |
Calculated Confidence Intervals of Analytical CV | Lower: 7.49, Upper: 9.56 |
Measurand Mean | 103.3 |
Measurand Min | |
Measurand Max | |
Measurand SD |